Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:age |
adults
children |
| gptkbp:ATCCode |
gptkb:J07BC02
|
| gptkbp:broadcastOn |
two doses
|
| gptkbp:contains |
inactivated hepatitis A virus
|
| gptkbp:contraindication |
acute febrile illness
hypersensitivity to vaccine components |
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:Canada gptkb:France gptkb:India gptkb:United_Kingdom |
| gptkbp:firstDose |
at chosen date
|
| gptkbp:form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avaxim
|
| gptkbp:indication |
immunization against hepatitis A
|
| gptkbp:manufacturer |
gptkb:Sanofi_Pasteur
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:secondDose |
6 to 12 months after first dose
|
| gptkbp:sideEffect |
fever
fatigue headache pain at injection site |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
prevention of hepatitis A
|
| gptkbp:bfsParent |
gptkb:hepatitis_A_vaccine
gptkb:Hepatitis_A_vaccine |
| gptkbp:bfsLayer |
7
|